216 related articles for article (PubMed ID: 25752894)
1. Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer.
Enshaei A; Robson CN; Edmondson RJ
Ann Surg Oncol; 2015 Nov; 22(12):3970-5. PubMed ID: 25752894
[TBL] [Abstract][Full Text] [Related]
2. Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers.
Kawakami E; Tabata J; Yanaihara N; Ishikawa T; Koseki K; Iida Y; Saito M; Komazaki H; Shapiro JS; Goto C; Akiyama Y; Saito R; Saito M; Takano H; Yamada K; Okamoto A
Clin Cancer Res; 2019 May; 25(10):3006-3015. PubMed ID: 30979733
[TBL] [Abstract][Full Text] [Related]
3. The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review.
Parpinel G; Laudani ME; Piovano E; Zola P; Lecuru F
Cancer Control; 2023; 30():10732748231159553. PubMed ID: 36847148
[TBL] [Abstract][Full Text] [Related]
4. A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study.
Karlsen MA; Fagö-Olsen C; Høgdall E; Schnack TH; Christensen IJ; Nedergaard L; Lundvall L; Lydolph MC; Engelholm SA; Høgdall C
Tumour Biol; 2016 Sep; 37(9):12619-12626. PubMed ID: 27440204
[TBL] [Abstract][Full Text] [Related]
5. Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
Horowitz NS; Larry Maxwell G; Miller A; Hamilton CA; Rungruang B; Rodriguez N; Richard SD; Krivak TC; Fowler JM; Mutch DG; Van Le L; Lee RB; Argenta P; Bender D; Tewari KS; Gershenson D; Java JJ; Bookman MA
Gynecol Oncol; 2018 Jan; 148(1):49-55. PubMed ID: 29174555
[TBL] [Abstract][Full Text] [Related]
6. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of urinary tract infection based on artificial intelligence methods.
Ozkan IA; Koklu M; Sert IU
Comput Methods Programs Biomed; 2018 Nov; 166():51-59. PubMed ID: 30415718
[TBL] [Abstract][Full Text] [Related]
8. CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy.
Pelissier A; Bonneau C; Chéreau E; de La Motte Rouge T; Fourchotte V; Daraï E; Rouzier R
Gynecol Oncol; 2014 Dec; 135(3):542-6. PubMed ID: 25223808
[TBL] [Abstract][Full Text] [Related]
9. A combined neural network and decision trees model for prognosis of breast cancer relapse.
Jerez-Aragonés JM; Gómez-Ruiz JA; Ramos-Jiménez G; Muñoz-Pérez J; Alba-Conejo E
Artif Intell Med; 2003 Jan; 27(1):45-63. PubMed ID: 12473391
[TBL] [Abstract][Full Text] [Related]
10. External validation of two prediction models of complete secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer.
van de Laar R; Massuger LF; Van Gorp T; IntHout J; Zusterzeel PL; Kruitwagen RF
Gynecol Oncol; 2015 May; 137(2):210-5. PubMed ID: 25677063
[TBL] [Abstract][Full Text] [Related]
11. A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.
Ghisoni E; Katsaros D; Maggiorotto F; Aglietta M; Vaira M; De Simone M; Mittica G; Giannone G; Robella M; Genta S; Lucchino F; Marocco F; Borella F; Valabrega G; Ponzone R
J Ovarian Res; 2018 May; 11(1):42. PubMed ID: 29843747
[TBL] [Abstract][Full Text] [Related]
12. A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection.
Angioli R; Capriglione S; Aloisi A; Ricciardi R; Scaletta G; Lopez S; Miranda A; Di Pinto A; Terranova C; Plotti F
Ann Surg Oncol; 2015 Dec; 22(13):4217-23. PubMed ID: 25808099
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Chemotherapy Increases R0 Cytoreduction Rate But Does Not Improve Final Outcome in Advanced Epithelial Ovarian Cancer.
Medina-Franco H; Cortés-González R; Lambreton-Hinojosa F; Fimbres-Morales A; Vargas-Siordia JC
Ann Surg Oncol; 2017 May; 24(5):1330-1335. PubMed ID: 27995454
[TBL] [Abstract][Full Text] [Related]
14. Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models.
Laios A; Gryparis A; DeJong D; Hutson R; Theophilou G; Leach C
J Ovarian Res; 2020 Sep; 13(1):117. PubMed ID: 32993745
[TBL] [Abstract][Full Text] [Related]
15. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.
Bachmann C; Brucker SY; Kraemer B; Rothmund R; Staebler A; Fend F; Wallwiener D; Grischke EM
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1475-80. PubMed ID: 25739827
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients.
Shim SH; Lee SJ; Kim SO; Kim SN; Kim DY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2015 Jan; 136(1):30-6. PubMed ID: 25448457
[TBL] [Abstract][Full Text] [Related]
17. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
[TBL] [Abstract][Full Text] [Related]
18. Machine learning for improved pathological staging of prostate cancer: a performance comparison on a range of classifiers.
Regnier-Coudert O; McCall J; Lothian R; Lam T; McClinton S; N'dow J
Artif Intell Med; 2012 May; 55(1):25-35. PubMed ID: 22206941
[TBL] [Abstract][Full Text] [Related]
19. CT scan does not predict optimal debulking in stage III-IV epithelial ovarian cancer: a multicentre validation study.
MacKintosh ML; Rahim R; Rajashanker B; Swindell R; Kirmani BH; Hunt J; Brockbank E; Barton DP; Clayton RD
J Obstet Gynaecol; 2014 Jul; 34(5):424-8. PubMed ID: 24725017
[TBL] [Abstract][Full Text] [Related]
20. Prognostic predictive value of total lesion glycolysis from 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer.
Liao S; Lan X; Cao G; Yuan H; Zhang Y
Clin Nucl Med; 2013 Sep; 38(9):715-20. PubMed ID: 23856825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]